IGFBP2 and skin squamous cell carcinoma: Interestingly, neither Squamous Cell Carcinoma in situ (SCCIS) nor cSCC showed a significant upregulation of ALDH3A1 and IGFBP2, and ALDH3A1 was even found to be downregulated in cSCC.